Literature DB >> 7591113

Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites.

A Karlsson1, M Markfjäll, N Strömberg, C Dahlgren.   

Abstract

The prevailing view of neutrophil NADPH-oxidase activation during interaction with bacteria is that the production of toxic oxygen metabolites should be directed into the phagosome containing the engulfed prey. However, in this report we show that a common Escherichia coli strain, HB101, may induce a release of neutrophil oxygen metabolites to the extracellular milieu. This phenomenon is dependent on three factors: (i) the mobilization (upregulation) of neutrophil secretory vesicles prior to interaction with the bacteria, (ii) soluble bacterial factors binding to the formylmethionyl-leucyl-phenylalanine receptor and tentatively identified as formylated peptides, and (iii) a bacterium-associated priming factor identified as lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591113      PMCID: PMC173662          DOI: 10.1128/iai.63.12.4606-4612.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Separation of human neutrophil plasma membrane from intracellular vesicles containing alkaline phosphatase and NADPH oxidase activity by free flow electrophoresis.

Authors:  H Sengeløv; M H Nielsen; N Borregaard
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Altered O2-/H2O2 production ratio by in vitro and in vivo primed human neutrophils.

Authors:  P Follin; C Dahlgren
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

3.  Temporal adaptation of human neutrophil metabolic responsiveness to the peptide formylmethionyl-leucyl phenylalanine: a comparison between human neutrophils and granule-depleted neutrophil cytoplasts.

Authors:  C Dahlgren
Journal:  Cell Biochem Funct       Date:  1990-01       Impact factor: 3.685

4.  Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.

Authors:  N Borregaard; L Christensen; O W Bejerrum; H S Birgens; I Clemmensen
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring.

Authors:  H Mundi; B Björkstén; C Svanborg; L Ohman; C Dahlgren
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Mechanisms in neutrophil priming: characterization of the oxidative response induced by formylmethionyl-leucyl-phenylalanine in human exudated cells.

Authors:  P Follin; G Briheim; C Dahlgren
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

7.  Identification of formyl Met-Leu-Phe in culture filtrates of Helicobacter pylori.

Authors:  M F Broom; R M Sherriff; D Munster; V S Chadwick
Journal:  Microbios       Date:  1992

8.  Quartz selectively down-regulates CR1 on activated human granulocytes.

Authors:  J Lundahl; C Dahlgren; A Eklund; J Hed; R Hernbrand; G Tornling
Journal:  J Leukoc Biol       Date:  1993-01       Impact factor: 4.962

9.  Neutrophil killing of two type 1 fimbria-bearing Escherichia coli strains: dependence on respiratory burst activation.

Authors:  R Lock; C Dahlgren; M Lindén; O Stendahl; A Svensbergh; L Ohman
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  Regulation of chemoattractant receptor interaction with transducing proteins by organizational control in the plasma membrane of human neutrophils.

Authors:  A J Jesaitis; J O Tolley; G M Bokoch; R A Allen
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  8 in total

1.  Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

Authors:  J E Hughes; J Stewart; G R Barclay; J R Govan
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.

Authors:  Pablo Iribarren; Ye Zhou; Jinyue Hu; Yingying Le; Ji Ming Wang
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils.

Authors:  J Mott; Y Rikihisa
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Uropathogenic Escherichia coli triggers oxygen-dependent apoptosis in human neutrophils through the cooperative effect of type 1 fimbriae and lipopolysaccharide.

Authors:  Robert Blomgran; Limin Zheng; Olle Stendahl
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 6.  The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Authors:  David A Dorward; Christopher D Lucas; Gavin B Chapman; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

7.  The Prolyl Isomerase Pin1 Controls Lipopolysaccharide-Induced Priming of NADPH Oxidase in Human Neutrophils.

Authors:  Min Liu; Samia Bedouhene; Margarita Hurtado-Nedelec; Coralie Pintard; Pham My-Chan Dang; Shiyuan Yu; Jamel El-Benna
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

8.  Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming.

Authors:  Ekaterina A Golenkina; Svetlana I Galkina; Olga Pletjushkina; Boris Chernyak; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.